• Phosphatase Inhibitor Cocktail 1 for Chordoma Signaling

  2026-09-25

  Protect labile phosphorylation signals while investigating how IDH1 inhibition reshapes chordoma biology. This workflow connects redox-metabolism findings to practical Western blot, immunoprecipitation, and phosphoproteomic experiments—without mistaking sample preservation for proof of mechanism.

• Camostat Mesilate: Designing Causal Assays

  2026-09-25

  Camostat Mesilate can reveal how protease-linked processes influence epithelial sodium-channel function and fibrotic signaling—but a pathway-level effect is not proof of direct target engagement. This article shows how to build assays that separate those claims, using structure-guided proteomimetic research as a contrasting example of direct protein–protein interaction inhibition.

• GI 254023X: ADAM10 Inhibitor Workflows

  2026-09-24

  GI 254023X offers a selective way to probe ADAM10-dependent shedding, with practical applications in Notch1 signaling and endothelial barrier models. This workflow-focused guide shows how to pair target-engagement assays with functional readouts while keeping the distinction between ADAM10 research and BACE neurobiology clear.

• Bending Rigidity of the Red Blood Cell Membrane

  2026-09-24

  By separating the red blood cell cytoplasmic membrane from its spectrin network, Himbert and colleagues measured a low bending modulus of approximately 4–6 kBT using complementary scattering and simulation methods. The result helps explain why whole-cell and membrane measurements can differ, while emphasizing that membrane mechanics depend on the structure and length scale being studied.

• MG-132 Workflows for Proteasome and Endothelial Assays

  2026-09-23

  Use MG-132 as a short-pulse probe to test whether proteasomal turnover contributes to a candidate protein’s regulation—not as a stand-alone readout of one ubiquitin ligase. This workflow translates the WWP2–DDX3X endothelial-injury study into practical controls for ubiquitination, apoptosis assay, and cell cycle arrest studies.

• Hyaluronic Acid Sodium Salt for siRNA Nanoparticles

  2026-09-23

  Learn how to use Hyaluronic acid sodium salt as an extracellular matrix interface, nanoparticle coating, and assay variable in immune, infection, and tissue-modeling workflows. The guide translates a recent TDRD9-siRNA study into practical formulation, controls, troubleshooting, and validation steps.

• Aclacinomycin A for rDNA Damage Workflows

  2026-09-22

  Use Aclacinomycin A as a tunable topological-stress reagent to connect persistent ribosomal DNA lesions with PML-nucleolar associations, apoptosis, and proteasome-related responses. This workflow combines viability benchmarking with time-resolved imaging, helping distinguish early DNA-damage signaling from late, nonspecific cell death.

• IBDV VP3 Disrupts IRF7 Signaling to Aid Replication

  2026-09-22

  A 2025 study identifies IBDV VP3 as a viral antagonist of the chicken IRF7–IFN-β antiviral axis. By combining infection comparisons, IRF7 gain- and loss-of-function experiments, proteasome-pathway tests, and protein-interaction analyses, the authors show how very virulent IBDV promotes IRF7 loss to support replication.

• HNRNPU K181 Lactylation Rewires Serine Metabolism

  2026-09-21

  The reference study identifies HNRNPU K181 lactylation as a non-histone, lactate-responsive mechanism that stabilizes HNRNPU, preserves PHGDH transcripts, and promotes serine metabolic reprogramming in cervical cancer. Its combination of transcriptomic, proteomic, molecular, metabolic, and in vivo evidence provides a framework for connecting tumor lactate accumulation with post-transcriptional gene regulation and cancer growth.

• CerS6 Links Stress to Hepatocyte Mitochondrial Injury

  2026-09-21

  Liu et al. identify CerS6-derived mitochondrial C16:0 ceramide as a mechanistic link between corticosterone-associated stress and hepatocyte mitochondrial injury. By combining restraint stress, a corticosterone cell model, LC–MS/MS lipid profiling, pathway inhibition, and CerS6 knockdown, the study connects AMPK/p38 MAPK signaling with ceramide-mediated cytochrome c release.

• PR-619 for Reliable Cell Assays

  2026-09-20

  PR-619 (SKU A8212) is a cell-permeable, reversible deubiquitylating enzymes inhibitor for linking DUB activity with viability, proliferation, autophagy, and protein-stability readouts. This scenario-based guide covers assay compatibility, DMSO preparation, dose selection, interpretation of cytotoxicity, and practical vendor evaluation.

• DiscoveryProbe™ Library: Protease Inhibition Strategy

  2026-09-19

  The DiscoveryProbe Protease Inhibitor Library supports mechanism-first protease inhibition studies across biochemical and cellular models. This article shows how to convert library hits into defensible pathway hypotheses using phenotype, orthogonal assays, and the experimental logic of a plant stomatal-opening study.

• PR-619: Practical DUB Inhibition Workflow

  2026-09-18

  PR-619 is a cell-permeable, reversible deubiquitylating enzymes inhibitor for studying ubiquitinated-protein accumulation without directly blocking proteasomal catalytic activity. It is suited to controlled cell-based ubiquitination pathway research, autophagy-related assays, and exploratory cancer or neurodegeneration studies, but it should not be treated as a universal cellular dose or as a substitute for a proteasome inhibitor.

• WWP2–DDX3X Control of Diabetic Endothelial Injury

  2026-09-18

  You et al. identify endothelial WWP2 as a protective regulator of Type 2 diabetes mellitus-associated vascular injury and connect its loss to impaired DDX3X turnover. By combining patient single-cell data, endothelial-specific knockout mice, cultured endothelial cells, and ubiquitination assays, the study defines a JNK–WWP2–DDX3X axis with implications for diabetic vascular complication research.

• Caspase-3/7 Inhibitor I: Apoptosis Workflows

  2026-09-17

  Build cleaner apoptosis experiments with a reversible, cell-permeable inhibitor that separates executioner-caspase activity from upstream stress signaling. This guide applies the compound to Jurkat apoptosis assays and to mechanistic studies inspired by Candida krusei injury in bovine mammary epithelial cells.

723 records 1/49 page Next 12345 下5页 Last page